The Ministry of Health and Welfare sent an official letter saying, "Be aware of misuse of high expenses during non-face-to-face treatment."
As critics continued to point out that the obesity treatment "Wigobi" is being prescribed indiscriminately, the government asked for special attention to ...
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
Courts have long deferred to CMS’s decisions on implementation of laws that govern Medicare. The overturning of the Chevron ...
Let The Numbers Speak: Prescription Drug Provisions In The Inflation Reduction Act
The Inflation Reduction Act is unlikely to generate savings for taxpayers, while disrupting the market and creating perverse ...